샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514239

세계의 심장박동 관리(CRM) 기기 시장

Cardiac Rhythm Management (CRM) Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 274 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 심장박동 관리(CRM) 기기 시장은 2030년까지 239억 달러에 이를 것으로 예상

2023년에 185억 달러로 평가된 세계의 심장박동 관리(CRM) 기기 시장은 분석 기간 2023년부터 2030년까지 CAGR 3.8%로 성장할 전망이며, 2030년에는 239억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 제세동기는 CAGR 4.4%로 성장을 지속하고, 분석 기간 종료 시 113억 달러에 도달할 것으로 예측됩니다. 심장박동기 분야의 성장률은 분석 기간 동안 CAGR 3.6%로 추정됩니다.

미국 시장은 추정 50억 달러, 중국은 CAGR 6.6%로 성장 예측

미국의 심장박동 관리(CRM) 기기 시장은 2023년 50억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 50억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 6.6%로 전망됩니다. 다른 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 0.9%와 4.4%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 1.8%로 성장할 것으로 예측됩니다.

세계의 심장박동 관리(CRM) 기기 시장-주요 동향 및 촉진요인 요약

심장박동 관리(CRM) 기기는 불규칙한 심박 리듬 및 기타 관련 심장 질환의 진단 및 치료를 위해 의료 분야에서 매우 중요한 역할을 담당합니다. 이러한 장치에는 심박조율기, 이식형 제세동기(ICD), 심장 재동기 요법(CRT) 장치 등 적절한 심장 기능을 보장하도록 설계된 다양한 제품이 포함됩니다. 심박 조율기는 주로 일정한 심장 박동을 자극하는 전기 임펄스를 보내 서맥을 관리하는 데 사용됩니다. 한편, ICD는 심장의 리듬을 지속적으로 감시하고 심한 부정맥이나 갑작스런 심정지의 에피소드 중에 구명을 위한 충격을 주어 정상적인 리듬을 회복시킵니다. CRT는 심실 수축을 조정하고 각 심장 박동의 효율을 향상시키기 때문에 심부전 환자에게 특히 유용합니다. CRM 기기에서는 리드선(침금)을 필요로 하지 않고 감염 리스크와 수술 합병증을 경감하는 리드리스 페이스메이커의 개발 등 대폭적인 기술 진보를 볼 수 있습니다. 게다가 MRI에 대응한 CRM 장치도 등장해, 종래는 금기로 되어 있던 자기 공명 이미징을 안전하게 받을 수 있게 되었습니다.

CRM 기기 시장은 심혈관질환의 유병률 상승과 진보된 진단 및 치료 기술의 채용 증가에 의해 큰 성장을 이루고 있습니다. 심혈관 질환은 여전히 세계 사망의 주요 원인 중 하나이며 수백만 명의 사람들에게 영향을 미치고 효과적인 관리 솔루션에 대한 큰 수요를 창출하고 있습니다. 심장 질환을 앓고 있는 세계 인구의 노령화는 CRM 장비의 필요성을 더욱 높여줍니다. 또한 CRM 장비에 원격 모니터링 시스템을 통합하면 심장 리듬의 지속적인 실시간 모니터링이 가능하고 적시에 의료 개입이 쉬워지고 환자 케어에 혁명적인 변화가 생깁니다. 이러한 원격 시스템은 잠재적인 문제를 조기에 발견함으로써 환자의 예후를 개선 할뿐만 아니라 빈번한 통원 및 재입원의 필요성을 줄이고 결국 의료비를 줄입니다. 헬스케어 제공업체는 케어의 질을 높이기 위해 이러한 고급 CRM 장비를 채택하고 있습니다. 게다가 선진국 시장과 신흥국 시장 모두에서 유리한 상환 정책과 의료비 증가는 다양한 의료 환경에서 CRM 장비의 채택을 뒷받침하고 있습니다.

CRM 기기 시장의 성장은 기술의 진보, 심혈관 질환의 이환율 증가, 저침습 처치에 대한 선호도 증가 등 여러 요인에 의해 견인되고 있습니다. 무선 CRM 기기와 인공지능 통합 등의 기술 혁신으로 CRM 기기의 기능성과 환자 편의성이 크게 향상되어 채용이 증가하고 있습니다. 리드레스페이스메이커나 MRI 대응 기기 시장 개척은 환자에 의해 안전하고 다재다능한 옵션을 제공함으로써 대응 가능한 시장을 확대했습니다. 심혈관 질환의 유병률 증가와 노화로 인해 효과적인 관리 도구로서 CRM 기기에 대한 수요가 증가하고 있습니다. 게다가 외래 처치와 재택 케어 모델로의 이동은 휴대용 원격 모니터링이 가능한 CRM 기기에 대한 수요를 밀어 올리고 있습니다. 규제 당국의 승인과 기준은 이러한 장비의 안전성과 효능을 보장하며 시장 도입 추진에 중요한 역할을 합니다. 게다가 신흥 시장에서의 헬스케어 인프라의 확대나 심장케어 시설에 대한 투자 증가는 첨단 CRM 기술을 보다 폭넓은 환자층이 이용할 수 있게 해 새로운 성장 기회를 창출하고 있습니다. 혁신적이고 효과적인 심장 관리 솔루션에 대한 필요성 증가를 반영하여 CRM 장비 시장의 견조한 성장 궤도를 뒷받침합니다.

조사 대상 기업 예(총 34건)

  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic, Inc.
  • Physio-Control, Inc.
  • Schiller AG
  • ZOLL Medical Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

AJY 24.07.24

Global Cardiac Rhythm Management (CRM) Devices Market to Reach US$23.9 Billion by 2030

The global market for Cardiac Rhythm Management (CRM) Devices estimated at US$18.5 Billion in the year 2023, is expected to reach US$23.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Defibrillators, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the Pacemakers segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 6.6% CAGR

The Cardiac Rhythm Management (CRM) Devices market in the U.S. is estimated at US$5.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Cardiac Rhythm Management (CRM) Devices Market - Key Trends and Drivers Summarized

Cardiac Rhythm Management (CRM) devices are crucial in the medical field for diagnosing and treating irregular heart rhythms and other related cardiac conditions. These devices include a diverse array of products such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices, all designed to ensure proper heart function. Pacemakers are primarily used to manage bradycardia by sending electrical impulses to stimulate a consistent heartbeat. ICDs, on the other hand, continuously monitor heart rhythms and deliver life-saving shocks to restore normal rhythm during episodes of severe arrhythmias or sudden cardiac arrest. CRT devices are particularly beneficial for patients with heart failure, as they coordinate the contractions of the heart's ventricles, improving the efficiency of each heartbeat. The CRM device landscape has seen substantial technological advancements, such as the development of leadless pacemakers, which eliminate the need for leads (wires) and thereby reduce infection risks and procedural complications. Additionally, MRI-compatible CRM devices have emerged, allowing patients with these implants to safely undergo magnetic resonance imaging, which was previously contraindicated.

The market for CRM devices is experiencing significant growth driven by the rising prevalence of cardiovascular diseases and the increasing adoption of advanced diagnostic and therapeutic technologies. Cardiovascular diseases remain one of the leading causes of mortality worldwide, affecting millions of people and creating a substantial demand for effective management solutions. The aging global population, which is more susceptible to cardiac conditions, further drives the need for CRM devices. Moreover, the integration of remote monitoring systems in CRM devices has revolutionized patient care by enabling continuous, real-time monitoring of heart rhythms, thereby facilitating timely medical interventions. These remote systems not only improve patient outcomes by providing early detection of potential issues but also reduce the need for frequent hospital visits and readmissions, ultimately lowering healthcare costs. Healthcare providers are increasingly adopting these advanced CRM devices to enhance the quality of care. Additionally, favorable reimbursement policies and growing healthcare expenditure in both developed and emerging markets are bolstering the adoption of CRM devices across various healthcare settings.

The growth in the CRM devices market is driven by several factors, including technological advancements, the rising incidence of cardiovascular diseases, and the growing preference for minimally invasive procedures. Technological innovations, such as wireless CRM devices and the integration of artificial intelligence, have significantly enhanced the functionality and patient-friendliness of these devices, leading to increased adoption. The development of leadless pacemakers and MRI-compatible devices has expanded the addressable market by offering safer and more versatile options for patients. The increasing prevalence of cardiovascular diseases, coupled with an aging population, has heightened the demand for CRM devices as effective management tools. Moreover, the shift towards outpatient procedures and home-based care models has driven the demand for portable and remotely monitored CRM devices. Regulatory approvals and standards have also played a crucial role in propelling market adoption, ensuring the safety and efficacy of these devices. Furthermore, the expansion of healthcare infrastructure in emerging markets and rising investments in cardiac care facilities have generated new growth opportunities, making advanced CRM technologies more accessible to a broader patient population. These factors collectively underscore the robust growth trajectory of the CRM devices market, reflecting the increasing need for innovative and effective cardiac care solutions.

Select Competitors (Total 34 Featured) -

  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic, Inc.
  • Physio-Control, Inc.
  • Schiller AG
  • ZOLL Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiac Rhythm Management (CRM) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Diseases Spurs Demand for CRM Devices
    • Advances in Wireless CRM Technologies Propel Growth
    • Increasing Adoption of Remote Monitoring Systems Strengthens Business Case for CRM Devices
    • Technological Innovations in Leadless Pacemakers Expand Addressable Market Opportunity
    • Growing Awareness and Early Diagnosis of Cardiac Disorders Drive Market Adoption
    • Integration of AI in CRM Devices Generates Demand
    • Rising Healthcare Expenditure Sustains Market Growth
    • Aging Population and Associated Cardiac Conditions Propel Growth in CRM Device Utilization
    • Development of MRI-Compatible CRM Devices Expands Addressable Market
    • Increasing Investments in Cardiac Care Facilities Generate Opportunities for Market Expansion
    • Shift Towards Outpatient Procedures Spurs Growth in CRM Devices Market
    • Innovations in Battery Life and Device Longevity Strengthen Business Case for Adoption
    • Growing Use of CRM Devices in Emerging Economies Expands Addressable Market Opportunity
    • Focus on Reducing Hospital Readmissions Generates Demand for Advanced CRM Solutions
    • Rising Number of Cardiac Rehabilitation Programs Strengthens Business Case for CRM Devices
    • Focus on Personalized Medicine and Tailored Cardiac Treatments Drives Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Rhythm Management (CRM) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Resynchronization Therapy (CRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제